Morning Market Losers By: Benzinga via Benzinga January 05, 2015 at 09:57 AM EST Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) shares dropped 24.76% to $5.64 after the company reported final analysis of Phase 2a ... Read More >> Related Stocks: Amgen Brainstorm Cell Partner Comm Ltd ADR Starbucks Corp Transocean Ltd